AMY HATOK: Open Payments
NPI 1770593576 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 36 payments from 13 companies in 2025. Trend: 2023 $416 · 2024 $606 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $217 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| ABBVIE INC. | 5 | $109 |
| PFIZER INC. | 4 | $80 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 2 | $36 |
| Stryker Corporation | 1 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: Auvelity, AIRSUPRA, QULIPTA, NURTEC ODT, UBRELVY, MOUNJARO, Wegovy, CLOTTRIEVER BOLD CATHETER.
Industry payments across VA — which companies pay providers there.
